Perceptive Advisors LLC Athenex, Inc. Transaction History

Perceptive Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.24 - $1.11 $480,000 - $2.22 Million	2,000,000 Added 14.78%	15,532,467 $4.18 Million
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $20.5 Million - $29.1 Million	2,000,000 Added 17.34%	13,532,467 $161 Million
Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $7.65 Million - $14.2 Million	797,222 Added 7.43%	11,532,467 $176 Million
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $11.1 Million - $19.2 Million	913,127 Added 9.3%	10,735,245 $131 Million
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $44.6 Million - $93.6 Million	4,726,096 Added 92.74%	9,822,118 $188 Million
Q4 2018 Feb 14, 2019	BUY	$10.24 - $15.49 $22.8 Million - $34.5 Million	2,226,494 Added 77.59%	5,096,022 $32.6 Million
Q3 2018 Nov 14, 2018	BUY	$15.53 - $19.97 $41.6 Million - $53.5 Million	2,679,528 Added 1410.28%	2,869,528 $44.6 Million
Q1 2018 May 15, 2018	BUY	$13.53 - $17.47 $2.57 Million - $3.32 Million	190,000 New	190,000 $3.23 Million

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.